sCD40L levels in platelet-poor plasma of patient cohort. Circulating levels of sCD40L in platelet-poor plasma were significantly lower in patients on treatment (■) compared with pretreatment (●, P = .02). As comparison, levels of sCD40L in normal healthy controls are shown (♦).